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ABSTRACT 
 
Blood pressure and heart rate is known to increase during smoking. These effects are 
specifically associated with nicotine while the other components of tobacco smoke seem to 
be of minor importance. It is becoming increasingly clear that fetal nicotine exposure, 
through transfer of nicotine via the placenta, has numerous consequences that is detrimental 
to the health of the fetus and that these effects may last into adulthood or perhaps even 
manifest itself later in life. In this study, we investigated the effects of maternal nicotine 
exposure during pregnancy and lactation on the blood pressure of the male offspring. A 
preliminary study indicated that the female offspring do not become hypertensive. We were 
particularly interested to determine whether hypertension in the offspring could be prevented 
or attenuated by vitamin C (an antioxidant) therapy. 
When confirmed to be pregnant, female Wistar rats were divided into four groups. The 
control group (group 1) received saline (1ml/day, s.c), the animals in group 2 received 
nicotine (1mg/kg/day in ml, s.c), group 3 animals received a combination of saline (1 ml/day 
s.c.) and vitamin C (1g/l in drinking water) and the animals in group 4 received a 
combination of nicotine (1mg/kg/day, s.c) and vitamin C (1g/l in the drinking water) during 
pregnancy and lactation. At weaning eight animals from group 2 received vitamin C in the 
drinking water (1g/l) until the end of the experiment. Blood pressure and body weight were 
measured every two weeks for 5 months. Blood samples were collected, and serum prepared 
at 3 weeks and at 5 months for biochemical analysis. Total antioxidant capacity (TAC), 
thiobarbituric acid reactive substances (TBARS) and superoxide dismutase (SOD) assays 
were determined at 3 weeks; TAC was also measured at five months. After 5 months, the 
 
 
 
 
  vi  
 
animals were sacrificed and abdominal aorta was excised for histological (H and E staining) 
and IHC (AGE) evaluation. 
From the data generated in this study, it was evident that maternal nicotine exposure during 
pregnancy and lactation increased blood pressure of male offspring but not female offspring. 
Exposure to nicotine during pregnancy and lactation significantly increased systolic blood 
pressure from 115±4.6 mm Hg in the first month to 147±6.1 mm Hg at five months (P<0.05), 
diastolic blood pressure was increased from 84±3.4 mm Hg in the first month to 110±7.2 mm 
Hg at 5 months (P<0.05) and MAP was increased from 94.8±3.8 mm Hg in the first month to 
121±6.4 mm Hg at 5 months. Interestingly the MAP of the nicotine group was normal during 
the first two months. HR was similar in all groups at 5 weeks and 5 months. Maternal vitamin 
C supplementation in rats exposed to nicotine during pregnancy and lactation did not prevent 
development of hypertension of the offspring (MAP=121±6.4 mm Hg in the nicotine group 
vs 113.4±1.7 mmHg in the nicotine and vitamin C group, P>0.05). Supplementation with 
vitamin C in the drinking water after weaning significantly reduced blood pressure of the 
offspring (MAP=121±6.4 mm Hg vs 97.6±2.9 mm Hg respectively, P<0.05). No significant 
difference was found in any of the biochemical assays. Maternal nicotine exposure during 
pregnancy and lactation leads to alteration in aorta structure as evaluated by H and E staining. 
Structural alterations include protrusion of the intima and irregular arrangement of the 
vascular smooth muscle cells (VSMC) in the tunica media. Maternal vitamin C 
supplementation and vitamin C supplementation after weaning did not prevent the structural 
alteration of the aorta. Immunohistochemistry (IHC) indicated that the accumulation of 
AGE’s in the nicotine group was stronger than in the control group. In conclusion, we show 
for the first time that hypertension induced by maternal nicotine exposure can be reversed 
after weaning by supplementation with vitamin C, an antioxidant. 
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CHAPTER ONE 
       INTRODUCTION 
 
The Fetal origin of adult disease theory was first introduced by Barker (1995). It proposes 
that alterations in the environment within which the fetus develops, such as nutritional status, 
oxygenation status and exposure to toxic substances, may change the structure, physiology 
and metabolism of the individual in such a manner that it predisposes the offspring to 
cardiovascular, metabolic and endocrine diseases in adult life (Godfrey & Barker, 2000). 
Changes in the environment within which the fetus and neonate develop might, therefore, 
have a profound effect on the future health of the individual. 
 
Nicotine is the principal alkaloid present in the tobacco plant, which belongs to the 
nightshade family, and represents about 0.6-3.0% of the dry weight of tobacco (Tassew and 
Chandravanshi, 2015). Neuronal nicotinic acetylcholine receptors are pentamers with a 
unique conformation of alpha (α2- α10) and beta (β2-β4) subunits resulting in different 
receptor subtypes found throughout the brain, which is cause of nicotine addiction (Jiloha, 
2010).In addition to being a stimulant drug, nicotine can also act as an antidepressant and is 
highly addictive (Hughes et al., 2014). Its neurochemical and metabolic effects are similar to 
those of other drugs such as cocaine, amphetamine and morphine, which have strong 
addictive properties (Pontieri et al., 1996). 
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Studies have also shown that exposure to nicotine is associated with the development of some 
chronic diseases such as, hypertension, obesity and type 2 diabetes (Gao et al., 2005; Gao et 
al., 2008). It has been reported that blood pressure increases during smoking, due to the 
presence of nicotine in tobacco smoke (Xiao et al., 2014). This because the nicotine affects 
the cardiovascular system in two ways: 1) it increases heart rate and 2) it causes narrowing of 
arteries which increases risk of developing peripheral artery disease (PAD), affecting the 
arteries that supply the kidneys, stomach, arms, legs and feet, and also leads to increases in 
blood pressure. 
 
Epidemiological studies have demonstrated that exposure to maternal nicotine is associated 
with an increased risk of elevated blood pressure in postnatal life (Xiao et al., 2008). Xiao et 
al (2008) reported that, in utero exposure to maternal nicotine (6 mg/kg/day) had no effect on 
baseline BP but significantly increased Ang II stimulated BP in male but not female 
offspring. On the other hand, Gao et al (2008)has showed that blood pressure was increased 
at 14 weeks of age in the nicotine (1 mg/kg/day) exposed male offspring. 
 
Previous studies have reported that the harmful effects of nicotine is due to a disturbance in 
the capacities of endogenous antioxidant defences in which the activity of the antioxidant 
system is overwhelmed by reactive oxygen species generation (Halliwell and Whiteman, 
2004). It has however also been suggested that the toxicity of nicotine induced oxidative 
stress can be modulated by antioxidants (McIntyre et al., 1999). Vitamin C is the major 
essential water-soluble antioxidant in human serum and is able to reduce the oxidative 
properties of toxic substances (Perai et al., 2014). As an antioxidant, vitamin C helps in 
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preventing oxidative stress by directly scavenging oxygen-derived free radicals, such as 
superoxide anions or hydroxyl radicals (Nagaraj and Paunipagar, 2014). An in vitro study has 
also shown advanced glycation end products (AGE’s) to be part of the complicated 
interaction between oxidative stress and vascular damage (Wihler et al., 2005). 
 
1.2. The objectives of this study: 
In view of the above the objectives of this study were to determine whether: 
1. Low dose (1 mg/kg/day) maternal nicotine exposure during pregnancy and lactation will 
induce hypertension in the offspring. We also wanted to determine whether both male and 
female offspring are affected. 
2. Hypertension induced by maternal nicotine exposure is present at weaning or only 
develops later in life. 
3. Hypertension induced by maternal nicotine exposure can be prevented or attenuated by 
vitamin C supplementation during the perinatal period or after weaning. 
4. Low dose maternal nicotine exposure effects serum antioxidant capacity, aorta morphology 
and expression of AGE in the aorta. 
5. The above can be prevented or reduced by vitamin C supplementation. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1. Nicotine 
Nicotine is the principal alkaloid present in the tobacco plant, which belongs to the 
nightshade family, and represents about 0.6-3.0% of the dry weight of tobacco. It is a 
hygroscopic, colorless and an oily liquid that is readily soluble in alcohol (Tassew and 
Chandravanshi, 2015). Nicotine is a potent parasympathomimetic alkaloid and a stimulant 
drug (Zhouet al., 2014). The chemical structure of nicotine is shown in figure 2.1. 
 
 
 
Figure 2.1: The structure of nicotine (Seeman et al., 1999). 
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When nicotine is exposed to ultraviolet light or other oxidizing agents, it transforms to 
nicotinic oxide, nicotine acid (Vitamin B3) and then to methylamine (figure 2.2), which may 
cause harm to the body. 
 
Figure 2.2: Illustration of how nicotine transforms to methylamine. 
 
In addition to being a stimulant drug, nicotine can also act as an antidepressant and is highly 
addictive (Hughes et al., 2014). Its neurochemical and metabolic effects are similar to those 
of other drugs which have strong addictive properties such as cocaine, amphetamine and 
morphine (Pontieri et al., 1996). Studies have also shown that exposure to nicotine is 
associated with the development of hypertension, obesity and type 2 diabetes (Gao et al., 
2005; Gao et al., 2008). 
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2.1.1-Biosynthesis, metabolism, excretion and therapeutic effects of nicotine 
Nicotine biosynthesis from tobacco roots is promoted by cutting or removal of the apex of the 
tobacco plant (Xiet al.,  2005). The pathway of nicotine biosynthesis in tobacco roots is still 
unclear, but some studies have suggested that the biosynthetic pathway of nicotine is through 
the interaction between the two cyclic structures that compose nicotine. The pyridine ring of 
nicotine is synthesized from niacin (nicotinic acid), while the pyrrolid one is synthesized from 
N-methyl-Δ1-pyrrollidium a cation (Shoji and Hashimoto, 2013) through two independent 
synthetic pathways, the nicotinamide adenine dinucleotide (NAD) pathway for niacin and the 
tropane pathway for N-methyl-Δ1-pyrrollidium cation.  
 
The major organ responsible for the metabolism of nicotine is the liver, mainly by 
cytochrome P450 enzymes (CYPs) (Earla et al., 2014). Nicotine metabolism is influenced by 
genetic factors, age and sex, use of estrogen-containing hormone preparations, pregnancy, 
kidney disease, medications, and smoking itself (Benowitz and Jacob, 1994). The lungs and 
kidneys have also been reported to play a part in the chemical breakdown of nicotine. In 
humans about 70–80% of nicotine is converted to cotinine through two stages. Firstly, 
nicotine is metabolized primarily by CYP2A6 to produce nicotine-Δ1′ (5′)-iminium, and 
secondly, it is the catalysed by a cytoplasmic aldehyde oxidase to produce cotinine (Wong, 
2015). Cotinine is the most widely used biomarker of nicotine intake. It may be measured in 
blood, urine, saliva, hair, or nails. Only 10-15% of nicotine absorbed by a smoker appears as 
unchanged cotinine in the urine. The remainder is converted to metabolites, primarily trans–
3′–hydroxycotinine (33–40%), cotinine glucuronide (12–17%), and trans–3′–hydroxycotinine 
glucuronide (7–9%)(Benowitzet al., 1994; Hukkanenet al., 2005). Cotinine can also be 
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determined in the urine of infants whose mothers have been exposed to nicotine during 
pregnancy or lactation (Benowitz et al.,  2009). Figure 2.3 below shows the transformation of 
nicotine in the systemic circulation. 
 
 
Figure 2.3: Transformation of nicotine into cotinine by cytochrome P 450 (Vellosaet al., 2007). 
 
Since the metabolism of cotinine is much slower than that of nicotine, the rate of metabolism 
of nicotine can be determined by measuring blood levels of cotinine after administration of a 
known dose of nicotine.  
 
As mentioned earlier, excretion of nicotine could be via urine, feaces, bile, saliva, gastric 
juice, sweat and breast fluid (Mishra et al., 2015; Nakajima et al., 2002). When nicotine is 
given to animals (like rats), it has been shown that around 55% is excreted in urine.  Animal 
studies have shown that the pH of urine has an effect on the rate of nicotine excretion. When 
the pH of the urine is alkaline, it leads to a decrease in nicotine excretion, and when the pH of 
the urine is acidic, it leads to an increase in nicotine excretion (Beckett et al., 1965). Ascorbic 
acid or vitamin C may have an influence on urinary excretion and metabolism of nicotine as it 
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was reported by Evans et al. (1999) that ascorbic acid leads to an increase in the urinary 
excretion of cotinine and nicotine (Dawson et al., 1999). 
 
Neuronal nicotinic acetylcholine receptors are pentamers with a unique conformation of alpha 
(α2- α10) and beta (β2-β4)subunits resulting in different receptor subtypes that are found 
throughout the brain, and the main cause of nicotine addiction are mediated via these 
receptors (Jiloha, 2010).The different areas in the brain contain different nicotine cholinergic 
receptor subtypes, which have different chemical conductance of sodium and calcium, and 
also different sensitivity to different nicotine agonists, resulting in correspondingly different 
pharmacological actions.  
 
As a therapeutic agent, nicotine can be used as a drug in the treatment of some diseases 
(Raupach et al., 2012). It has rewarding psychopharmacologic effects such as tranquilization, 
weight loss, decreased irritability, reduction in craving for cigarettes and other tobacco 
products, increased alertness, and improved cognitive function (Cary, 2001). A few 
experimental systems have established that nicotine causes weight loss via reduced appetite 
and increased metabolic rate (Grebenstein et al., 2013). It can encourage the release of 
serotonin, which has an important role in reducing body weight. S-nicotine, a product of 
nicotine metabolism (Park et al., 1993) has some beneficial effects on the treatment and 
protection against a number of diseases such as Parkinson's disease and Alzheimer's disease 
(Lopez-Arrieta and Sanz, 2001; Thiriez et al., 2011). Unfortunately, S-nicotine has side 
effects on the cardiovascular and digestive system, limiting its use as a therapeutic agent 
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(Girard et al., 2000). (R)-nicotine, which is also found in cigarette smoke, has been studied 
for its anxiolytic effects (Salas et al., 2003).  
 
2.1.2. Harmful effects of nicotine  
It has been reported that blood pressure increases during smoking, as a result of nicotine in 
tobacco smoke (Xiao et al., 2014). Nicotine affects the cardiovascular system in two ways: 1) 
it increases heart rate and 2) nicotine has effects on arteries by remodelling the artery and this 
leads to an increased risk of developing peripheral artery disease (PAD), affecting the arteries 
that supply the kidneys, stomach, arms, legs and feet and also leads to increase in blood 
pressure. The effect of nicotine on coronary heart disease is via accelerated atherogenesis, 
hyperlipidemia and dysfunctional endothelial cells (Benowitz, 1991). Nicotine can also play a 
role in stroke by altering the function of the blood-brain barrier and disruption of normal 
endothelial cell function (Hawkins et al., 2002). In addition, nicotine increases free fatty acid 
(FFA) levels, with some studies showing that people who suffer from heart disease always 
have high free fatty acid levels which facilitate the development of coronary heart disease 
(Papathanasiou et al., 2014). 
 
In adults, it was shown that the cardio-ankle vascular index (CAVI) was increased by 
exposure to nicotine. The CAVI reflects the stiffness of some arteries in the body such as the 
aorta, femoral artery, and tibial artery (Noike et al., 2010). The cardio-ankle vascular index is 
used as a clinical marker for evaluation of atherosclerosis and arteriosclerosis in patient with 
essential hypertension (Okura et al., 2007). In hypertension patient’s aortic stiffness is an 
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independent predictor of cardiovascular mortality, fatal and non-fatal coronary events, and 
fatal strokes (Laurent et al., 2001). Nicotine is believed to alter the structural and functional 
characteristics of vascular smooth muscle and endothelial cells by enhancing endothelial 
proliferation and increased atherosclerotic plaque formation. Neovascularization stimulated 
by nicotine has also been suggested to help the progression of atherosclerotic plaque. These 
effects lead to myointimal thickening, atherogenic and ischemic changes that increase the 
incidence of hypertension (Mishra et al., 2015). It has been reported that atherosclerosis and 
related diseases are due to vascular disorders including endothelial dysfunction (Rajendran et 
al., 2013). A study has indicated that vascular responses in adult offspring from adverse 
intrauterine environments were impaired in a gender-specific and age-dependent manner; 
with males more profoundly affected (Hemmings et al., 2005).  
 
In adulthood, the relationship between nicotine and obesity is incompletely understood 
(Chioleroet al., 2007). In adults, studies show that nicotine could reduce appetite via increases 
energy expenditure (EE) (Hofstetter et al., 1986). Other studies showed that light smokers 
have a lower body weight than do heavy smoker (Bamia et al., 2004; Chiolero et al., 2007). 
 
In humans, exposure to nicotine during pregnancy and lactation leads to alteration in 
endocrine and glucose homeostasis in the adult offspring, a metabolic change which is 
consistent with the disturbed glucose metabolism that may lead to type 2 diabetes (Jiang et 
al., 2013).In developed countries, it has been suggested that maternal cigarette smoking 
during pregnancy is a significant environmental contributor to fetal growth restriction which 
may later in life increase the risk for adult disorders (Reeves and Bernstein, 2014; Wideroe et 
al., 2003).Epidemiological studies have demonstrated that exposure to maternal nicotine is 
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associated with an increased risk of elevated blood pressure in postnatal life (Xiao et al., 
2008). Xiao et al (2008) reported that, in utero exposure to maternal nicotine had no effect on 
baseline BP but significantly increased Ang II stimulated BP in male but not female 
offspring. Gao et al (2008) also showed that blood pressure was increased at 14 weeks of age 
in the nicotine exposed offspring. They however did not measure BP in the young animals. 
 
Exposure of the lungs to nicotine via cigarette smoking has been reported to cause cancer of 
the lungs (Health and Services, 2004; Warren and Singh, 2013). In adults, exposure to 
nicotine is associated with a higher rate of respiratory diseases such as bronchitis, 
bronchiolitis, pneumonia, and asthma (Jaakkola and Maritta, 2002; Maritz, 2013), while there 
is also an enhancement in the risk of respiratory infections in children who are already 
regularly exposed to nicotine (Gurkan et al., 2000). In addition to this, it has also been shown 
that in monkeys, nicotine exposure can alter lung development and is associated with 
enlargement of airspaces and reduction in alveolar surface area (Sekhon et al., 1999; Sekhon 
et al., 2001; Sekhonet al., 2002). 
 
The effects of nicotine in the pathogenesis of hypertension, obesity, type 2 diabetes, 
cardiovascular disease, and respiratory diseases as explained in the above paragraphs have 
been reported to be mediated by oxidative stress related pathways (Cai and Harrison, 2000). 
The mechanism by which nicotine induces such oxidative stress will be discussed later. The 
other pathophysiological process by which nicotine induces hypertension includes stimulating 
the release of catecholamines (Czernin and Waldherr, 2003; Paton, 2013). A study has shown 
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that alteration in central catecholamine metabolism is considered to be causally related to 
increased blood pressure (Dev and Philip, 1996). 
 
2.1.3. Nicotine and Fetal programming  
Fetal or developmental programming is defined as the concept that a maternal stimulus or 
insult at a critical period in fetal development has a long-term impact on the offspring (Barker 
et al., 1993; Rabadan-Diehl and Nathanielsz, 2013). In modern paediatrics and developmental 
psychobiology, fetal programming is a concept which occurs when important physiological 
parameters are reset during intra-uterine development by environmental events. This resetting 
can endure into adulthood and affect the following generation to produce a trans-generational 
non-genetic disorder (such as Willi syndrome and Angelman syndrome). An example of this 
is the impact of changes in local fetal cellular environments on gene expression during the 
development of tissues and organs, which can result in long-term consequences for the 
function of those tissues and organs during childhood and adulthood (Godfrey et al., 2007).  
 
It is becoming increasingly clear that fetal exposure to nicotine has numerous consequences 
that is to the detriment of the health of the fetus, and that these effects may last well into 
adulthood. In pregnant women who smoke or use nicotine replacement therapy (NRT), 
nicotine crosses the placenta, concentrates in fetal blood and amniotic fluid, and is detectable 
in breast milk during lactation (Lambers and Clark, 1996; Mızrak et al., 2012). Exposure to 
nicotine during fetal development leads to diseases in adulthood, including obesity, 
hypertension, type-two diabetes, cardiovascular diseases (CVD) and some cancers.  
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Prenatal exposure to nicotine in rats is associated with increased postnatal body weight and 
higher levels of body fat in the fetus at gestational day 20 and during adulthood (Newman et 
al; 1999; Gao et al., 2005). Also, prenatal nicotine exposure has been reported to cause 
alterations in the central endocrine control of body weight homeostasis, which leads to 
increased body weight due to enhanced levels of the adipocyte hormone, leptin (Somm et al., 
2008; Oliveira et al., 2009).On the other hand, a number of other studies have also shown that 
the main effect of nicotine during gestation is caused by vasoconstriction of uterine placental 
blood vessels, leading to a reduced blood flow to the placenta and a reduction in the delivery 
of oxygen and nutrients to the fetus, which leads to a reduction in weight of the fetus 
(Cnattingius, 2004). 
 
In rats, exposure to nicotine during pregnancy and lactation has an effect on pancreatic 
development and postnatal beta cell survival and function (Bruin et al., 2007; Bruin et al., 
2008; Bruin et al., 2008). Animal studies have demonstrated that fetal and neonatal exposure 
to nicotine causes a permanent loss of beta cell mass beginning at birth, and this resulted in 
reduced islet size and number, as well as a reduction in beta cell neogenesis.  
 
It has been shown that there is an increased risk of hypertension in children born to women 
who smoke during pregnancy, and animal experiments have shown that this risk may be as a 
result of exposure to nicotine (Blake et al., 2000; Mund et al., 2013). Animal studies have 
also confirmed that exposure to nicotine during pregnancy causes elevated blood pressure in 
offspring after birth through dysfunction of endothelial cells and changes in the structure and 
function of the kidney (Pausová et al., 2003; Xiao et al., 2007; Mao et al., 2009). It has 
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suggested that nicotine has an effect on the regulation of vascular tone through alteration in 
per vascular adipose tissue (PVAT) composition and modulator function (Xiao et al., 2008), 
and this mechanism is associated with an increase in blood pressure (Gollasch and 
Dubrovska, 2004; Gao, 2008).  
 
Some epidemiological studies have shown that exposure to maternal nicotine during 
pregnancy also leads to adverse pulmonary functional outcomes in the offspring (Leslie, 
2013; England et al., 2015). Nicotine during pregnancy increases the risk of wheezing and 
asthma in the children up to 2 years of age (Lannerö et al., 2006; Rehan et al., 2012). Results 
from other studies suggest that there is also an impact on lung development and postnatal 
lung function as a consequence of maternal nicotine exposure (Hafström et al., 2005; Maritz, 
2008; Campos et al., 2009). Accelerated aging of the lung, characterized by microscopic 
emphysema, enlarged alveolar volume, increased flattening of alveoli and decreased internal 
surface area for gas exchange with increasing age have also been reported by (Maritz and 
Windvogel, 2003). 
 
Many studies have shown that fetal exposure to nicotine has an effect on the central nervous 
system (CNS) by alterations in cellular growth and activity of the central and peripheral 
nervous system (PNS), via cholinergic nicotine receptors (Palmer et al., 1992; Son and 
Winzer-Serhan, 2008; Dwyer et al., 2009). Prenatal nicotine exposure has an effect on 
neurobehavioral outcomes (such as attention-deficit hyperactivity disorder (ADHD) and 
decreased general cognitive functioning) in the offspring of women who were exposed to 
nicotine during pregnancy (Santiago and Huffman, 2014). 
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Animal models and human epidemiological studies, have reported that some diseases like 
dyslipidaemia and dysglycemia associated with disorders of metabolism of fatty liver disease, 
have relation to exposure to nicotine alone during fetal and neonatal development (Newman 
et al., 1999; Gao et al., 2005; Holloway et al., 2005). Table 2.1 summarized the harmful 
effects of nicotine on the body. 
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System/organ name Side effects Reference 
 
Cardiovascular system 
  
- Hear rate 
Increased heart rate and effect on arteries cause 
vasoconstriction. 
Maryann and 
Gronisch, 2009 
- Blood pressure Increase risk of elevated blood pressure (Hypertension). 
Xiao et al., 
2008 
- Vascular smooth 
muscle 
Alter the structural and functional characteristics of 
VSMC by enhancing endothelial proliferation and 
increased atherosclerotic plaque formation. 
Noike et al., 
2010 
- Stroke 
Altering the function of blood-brain barrier and 
disruption of normal endothelial cell function, causing 
stroke. 
Hawkins et al., 
2002 
Respiratory system 
Alter the structure and development of respiratory 
organs like the lungs. 
Sekhon et al., 
2002 
Central nervous system 
Alteration in cellular growth and activity of the central 
and peripheral nervous system via cholinergic nicotine 
receptors. 
Dwyer et al., 
2009 
Body weight 
Reduce appetite via increase energy expenditure and 
vasoconstriction of uterine placental blood vessels (Low 
body weight). 
Hofstetter et al., 
1986 
Type 2 diabetes 
Alteration in endocrine and glucose homeostasis which 
lead to disturbed glucose metabolism. 
Holloway et al., 
2005 
Pancreas 
Reduced islet size and number as well as a reduction in 
beta cell neogenesis. 
Bruinet al., 
2008) 
Cancers 
Induces a dose-dependent increase in proliferation of 
cancer cells (lung cancer and breast cancer). 
Dasgupta et al., 
2009 
 
Table 2.1:Summary of the harmful effects of nicotine on body tissue of adult. 
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2.2 Oxidative stress 
An oxidation reaction can produce free radicals, which can cause damage to the cells (Rahal 
etal., 2014). A free radical can be defined as an oxygen containing molecule that has one or 
more unpaired electrons, thus making it highly reactive with other molecules. Under normal 
physiologic conditions, free radicals are constantly produced as byproducts of mitochondria 
electron transport in the cellular respiratory chain, and also are inevitable byproducts of many 
cellular and extracellular redox reactions (Droge, 2002; Laloi et al., 2004).  
 
Antioxidants are molecules that prevent the oxidation of other molecules and are hence very 
important in the human body (figure 2.5). The antioxidant system can be divided into two 
main groups: antioxidant enzymes and non-enzymatic antioxidants. The latter consist of both 
endogenous molecules, such as glutathione and nicotinamide adenine dinucleotide phosphate 
(NADPH), and exogenous antioxidants, such as ascorbic acid (vitamin C) and tocopheol 
(vitamin E) (Schreibelt et al., 2007). Should the concentration of free radicals within the 
blood increase greatly because of excessive exposure to harmful factors such as smoking, 
then the endogenous antioxidant defence system may be inadequate and hence cannot 
neutralize or prevent the accumulation of free radicals which may cause dangerous mutations 
that destroy cells and cause chronic diseases.  
 
The antioxidants are distributed throughout the cell and body with only a small proportion 
accumulating in mitochondria, the cellular organelles where the generation of ROS may be 
high and the principle site of damage in the cells by free radicals. Mitochondria-target 
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antioxidants are able to reduce cell death arising from endogenous oxidative stress (Jauslin et 
al., 2003; Oyinloye et al., 2015). Research has shown that mitochondria-targeted antioxidants 
may be more effective as therapies than untargeted antioxidants. Vitamin C is an example of 
an antioxidant which targets the mitochondria (Augustin et al., 1997; Gruber et al., 2013).  
 
 
Figure 2.4: Antioxidant help by donating free electron and preventing cell damage (http://ins-jerusalem 
2014.com/images/Antioxidants). 
 
The term ―oxidative stress‖ refers to the total intracellular and extracellular conditions that 
lead to the accumulation of free radicals (e.g. reactive oxygen species (ROS)) in the body, 
hence causing damage of cell membranes by peroxidation of membrane lipids, oxidation of 
protein, inactivation of enzymes, and damaging to the genetic material in the cell nucleus via 
impairment of ribonucleic acid (RNA) synthesis and degradation of deoxyribonucleic acids 
(DNA). Certain diseases are the end-results of some pathological process initiated by ROS 
such as superoxide, singlet oxygen, hydroxyl radicals, hydrogen and organic peroxides (Lee 
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et al., 2012; Chen et al., 2013; Yang et al., 2013). These highly reactive oxygen species are 
known to be cytotoxic and often cause tissue injury in diseases such as cardiovascular 
diseases (CVD), neurological diseases, malignancies, renal diseases, diabetes, cancer, 
rheumatoid arthritis, inflammatory problems, skin diseases, aging, respiratory diseases, liver 
diseases and different types of viral infections (Irshad and Chaudhuri, 2002) (see figure 2.5). 
 
 
Figure 2.5: Oxidative Stress/Antioxidants & Chronic Disease (Rao and Rao, 2013). 
 
Under conditions of oxidative stress, unsaturated fatty acids (UFA) can undergo lipid 
peroxidation, one of the biomarkers of oxidative stress, to indicate whether oxidative stress 
has a role in damage of cells and tissues (Hong et al., 2014). Other studies determined the 
development or presence of lipid peroxidation(LPO) in the serum, some of them based on 
production of malondialdehyde by enzymatic processes(Ayala et al., 2014). The 
thiobarbituric acid reactive substance (TBARS) is a well-established method for lipid 
peroxidation determination in serum and other biological fluids (Yagi, 1979). Superoxide 
dismutases (SODs) are metalloenzymes that catalyze the dismutation of the superoxide anion 
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to molecular oxygen and hydrogen peroxide and thus form a crucial part of the cellular 
antioxidant defence mechanism (Fukai and Ushio-Fukai, 2011). It has an important role to 
protect the cells and tissues of the body against ROS and particularly superoxide anion 
radicals (Van Raamsdonk and Hekimi, 2012). Total tissue antioxidant capacity (TAC) is an 
assay used to measure the ability of endogenous systems to resist oxidative damage and 
current research has shown the TAC assay to be a reliable biomarker for many different 
pathophysiological conditions like heart and vascular diseases, diabetes mellitus, neurological 
and psychiatric disorders, renal disorders and lung diseases (Kusano and Ferrari, 2008).  
 
2.2.1. Oxidative stress and nicotine 
Previous studies have reported that the harmful effects of nicotine is due to a disturbance in 
the capacities of endogenous antioxidant defences in which the activity of the antioxidant 
system is overwhelmed by reactive oxygen species generation (Halliwell and Whiteman, 
2004). In nicotine administered rats, an increase in the generation of superoxide anion and 
hydrogen peroxide has been shown to lead to a decrease in the activities of the free radical 
scavenging enzymes such as SOD, catalase and glutathione peroxidase(Ashakumary and 
Vijayammal, 1996). Oxidative stress due to nicotine exposure has been reported in various 
tissues, including lung, vasculature and pancreas. 
 
A recent study Dhouib et al (2015) has reported that lung damage in rats that were 
chronically exposed to nicotine for 18 weeks was due to oxidative stress. It reported that 
chronic nicotine administration caused a significant increase in malondialdehyde (MDA) 
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level, SOD activity and catalase (CAT) activity in lung tissue suggesting oxidative damage 
(Dhouib et al., 2015). Nicotine induced oxidative stress in pancreatic islet cells has also 
recently been reported by Bhattacharjee et al (2016). Oxidative stress in pancreatic tissue is 
associated with lipid peroxidation (Chowdhury and Walker, 2008). Research into the 
oxidative damage to organs by nicotine has also been reported in a study conducted by 
Akkoyun and Karadeniz (2016). The authors reported that neonates exposed to nicotine 
intrauterine showed decreased total glutathione (GSH), glutathione peroxidase (GSH-Px) and 
SOD antioxidant activities. This may explain why nicotine decreases the capacity of 
antioxidant in the tissue and increased MDA levels which is a measure of the oxidation of 
lipids by ROS; it suggests that lipid peroxidation participate in the development of damage 
due to nicotine (Akkoyun and Karadeniz, 2016).  
 
2.2.2. Oxidative stress and hypertension  
Oxidative stress had been suggested to be involved in the pathogenesis of hypertension and 
atherosclerosis (Alexander, 1995; Montezano et al., 2015). Laboratory animal studies have 
established that angiotensin II (ANG II)-induced hypertension in the rat is accompanied by 
oxidative stress in blood vessels (Ishizaka et al., 1997; Ocaranza et al., 2014). Xiao et al 
(2011) reported antenatal nicotine exposure to increase the risk of hypertension in adult 
offspring as a result of programmed heightened oxidative stress and vascular reactivity via a 
Nox2-dependent mechanism. It has been suggested that the toxicity of nicotine induced 
oxidative stress can be modulated by antioxidants (McIntyre et al., 1999).  
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In the vasculature, the sources of ROS are from an assortment of different cell types including 
vascular smooth muscle cells (VSMCs), endothelial cells (EC), macrophages and fibroblasts. 
ROS has been shown to be an important factor in the regulation of many biological responses 
(Kunsch and Medford, 1999; Higashi et al., 2009), including stretch of the vessel wall in a 
pathological process involved in the development of hypertension.  
 
The increase of oxidative stress related to blood pressure is accompanied by a reduction in the 
most important antioxidant mechanisms hence antioxidant therapy (such as vitamin C) may 
relieve hypertension and invert the compensative up regulation of nitric oxide species 
isotypes in spontaneously hypertensive rats (SHR) (Vaziri et al., 2000). 
 
2.3. Vitamin C as an antioxidant 
Vitamin C (Vit C), also called ascorbic acid or ascorbate, is a water-soluble vitamin that is 
necessary for normal growth and development of the body. Vitamin C is the major essential 
water-soluble antioxidant in human serum and is able to reduce the oxidative properties of 
toxic substances (Perai et al., 2014). It is not synthesised in human due to a mutation in the 
gene coding for L-gulonolactone oxidase, which is necessary for the biosynthesis of vitamin 
C via glucuronic acid. It thus has to be supported in the human body via the intake of fruits, 
vegetables and vitamin C tablets (Carr and Frei, 1999; Naidu, 2003).     
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Some studies have shown that vitamin C acts in a non-enzymatic reaction as an electron 
donor to fulfil its role as an antioxidant in the prevention of many diseases. Vitamin C 
prevents other compounds from being oxidized by donating two electrons from the double 
bonds between the second and third carbon of its 6-carbon structure. As an antioxidant, 
vitamin C helps in preventing oxidative stress by directly scavenging oxygen-derived free 
radicals, such as superoxide anions or hydroxyl radicals (Nagaraj and Paunipagar, 2014). 
After the loss of an electron, the species formed is a free radical called ascorbyl free radical. 
Ascorbyl radical is relatively stable and fairly unreactive with a half-life of 10
-5
seconds, 
which is why ascorbate is preferred as an antioxidant (Nagaraj and Paunipagar, 2014). Figure 
2.6 below describes the chemical structure of the oxidation products of vitamin C. 
 
Figure 2.6:Vitamin C (ascorbate) and its oxidation products (Goszcz et al., 2015). 
 
It has been demonstrated that vitamin C protects nitric oxide (NO) from oxidation and 
increases its synthesis, and by this protection, it increases endothelial NO and ameliorates 
endothelial dysfunction (Taddei et al., 1998). Evidence also indicates that vitamin C is 
beneficial to healthy subjects and those with cardiovascular disease (CVD) (Brown and Hu, 
2001). A decrease in the concentration of vitamin C in plasma has been associated with 
hypertension and impaired endothelial function (Moran et al., 1993). Ascorbic acid has 
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beneficial effects on endothelium-dependent vasodilatation, and these beneficial effects may 
be related to the scavenging of oxygen free radicals (Akpaffiong and Taylor, 1998; Taddeiet 
al., 1998). Ascorbate stimulates vasodilatation in the brachial and coronary arteries  and by 
this dilation, vitamin C protects the body from many arterial diseases(Levine et al., 1996;  
Kugiyamaet al., 1997).  
 
2.4. Advanced glycation end products  
Advanced glycation end products (AGEs) are proteins and lipid molecules that become non-
enzymatically glycated when exposed to aldose sugars. AGEs are a complex and 
heterogeneous group of compounds that have been implicated in the pathophysiological 
process of some diseases, such as diabetes, renal failure, atherosclerosis and Alzheimer’s 
disease (Singh et al., 2002;Goldin et al., 2006; Merhi, 2013), hence, the study of advanced 
glycation end products has become one of the most important areas of research today. While 
studies on AGEs have only commenced in the last 20 years, the initial chemistry behind their 
mode of action has been described since the early 1900s, when it was noted that amino acids 
heated in the presence of reducing sugars developed a characteristic yellow-brown color 
(Wihler et al., 2005). Endogenous sources of AGEs are usually found in areas of the body 
where proteins and lipid glycation occurs, leading to the generation of AGEs. AGEs can also 
be derived from exogenous sources such as tobacco and foods (Cerami et al., 1997).  
 
In the body there are many variant receptors for AGEs, called receptors of advanced glycation 
end products (RAGEs). RAGE is a member of the immune-globulin superfamily of receptors 
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(Neeper et al., 1992; Sugaya et al., 1994)which become up-regulated when AGEs ligands 
accumulate in the body in a process of positive feedback activation (Mahajan and Dhawan, 
2013). Such up-regulation takes placein endothelial and smooth muscle cells (SMC) 
(Schmidtet al., 2001). 
 
Oxidative stress may induce formation of AGEs and AGEs may causes further oxidative 
stress (Jakus and Rietbrock, 2004). According to Yamagishi and Matsui (2010), there is 
evidence that AGEs and their signal-transducing receptor interaction evokes oxidative stress 
(Yamagishi and Matsui, 2010). An in vitro study has also shown AGE to be part of the 
complicated interaction between oxidative stress and vascular damage (Wihler et al., 2005). It 
has been demonstrated that the connection between AGEs and RAGE of endothelial cells 
leads to reduction in the defence mechanisms of the cellular antioxidants (e.g. glutathione and 
vitamin C) via generation of ROS, and this leads to further development of cellular oxidative 
stress (Basta et al., 2004). Current research has suggested a potential link between AGEs-
induced vascular calcification and oxidative stress (Wei et al., 2013).The study used nicotine 
to induce the calcification of the aorta resulting in an increase in the expression levels of aorta 
AGEs (Wei et al., 2013). It has also been suggested that RAGEs may have a role in stiffening 
of the vasculature by forming cross links through the collagen molecule, or by interaction 
with their cellular transduction receptors (Geroldi et al., 2005). Katz et al (2005) also 
hypothesized that nornicotine, a minor metabolite of nicotine, up regulate the expression of 
RAGE in the gingival of smokers and trigger the secretion of cytokines and reactive oxygen 
species which directly cause destruction of the tissues. 
 
 
 
 
  26  
 
CHAPTER THREE 
MATERIALS AND METHODS 
 
3.1.Ethical Clearance 
Ethical clearance for the study was obtained from the Ethical Committee of the University of 
the Western Cape (project no: 10/2/17). 
 
3.2.Materials 
The materials that were used in this study are presented in Table 3.1 and 3.2 below. 
 
Table 3.1: Biochemical assay kits and chemicals used in this study 
Kits and Chemicals SUPPLIER 
 
Total antioxidant capacity (TAC) test kit.(Ca.No:MAK187) Sigma-Aldrich (USA) 
Thiobarbituric acid reactive substances (TBARS) test kit (Ca.No: 
700870) 
Cayman-chemical 
 
Superoxide dismutases (SOD) test kit (Ca.No: 706002) Cayman-chemical 
Vitamin C (ascorbic acid) 
Sigma-Aldrich (USA) 
Pentobarbitone sodium Norpham medical (SA) 
Dimethyl sulfoxide (DMSO) 
Sigma-Aldrich (USA) 
High performance liquid chromatography (HPLC) grade water  
Kimix (SA) 
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Ethanol 
Servochem (SA) 
Formaldehyde 
Merck (Germany 
Di-Sodium hydrogen phosphate (anhydrous) (Na2HPO4) 
Kimix (SA) 
Sodium Di-hydrogen phosphate dehydrate (NaH2PO4.2H2O)  
Kimix (SA) 
Xylene 
Kimix (SA) 
Parafine wax 
Merck (Germany) 
DPX 
Kimix (SA) 
Haematoxylin and eosin (H& E) stain 
Merck (Germany) 
 
 
Table 3.2: Equipment 
Product 
Supplier 
 
Automatic tissue processor 
 
Leica, TP 1020 Germany) 
Autostainer machine 
Leica XL (Germany) 
Balance 
ae-Adam, Keynes (USA) 
Centrifuge 
Kent Scientific (USA) 
CODA blood pressures monitor 
Kent Scientific (USA) 
Embedding system 
Bobo (China) 
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Heating pad 
Doccol Corporation (USA) 
Light microscope 
Carl Zeiss (Germany) 
Microtome 
Leica, RM 2125RT (Germany) 
POLARstar omega spectrophotometer 
BMG Labtech (Germany) 
Vortex 
Kent Scientific (USA) 
Water bath 
Electrothermal (England) 
 
 
Nicotine used for this study was a gift from Dr Windvogel of the Department of Physiology, 
Stellenbosch University. 
 
3.3.Protocol for animal experimentation 
The animals used in this study were virgin Wistar rats and were bred in the animal facility at 
the University of the Stellenbosch. Only animals free from visible signs of diseases and ill 
health were used in this study. Animals had free access to food (chow) and tap water. The rats 
were kept in a room with controlled temperature (23C°), controlled lighting (lights on at 7 
a.m. and off at 7 p.m.) and controlled humidity.  
First study 
Female Wistar rats were given either saline (1 ml/day, s.c; control group), or nicotine (1 
mg/kg/day in 1 ml s.c; the nicotine group), during pregnancy and lactation. The blood 
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pressure of both female and male offspring was measured at 6 months of age. The 
experimental design of this study is shown in next flow diagram (figure 3.1). 
 
Figure 3.1: Flow diagram showing the experimental design for the first study. 
 
Second study 
In the second study, rats confirmed to be pregnant were randomly divided into four 
experimental groups. Group one (1) animals served as a control group while groups two to 
four (2-4) were treated as indicated below. Eight animals from group 2 received vitamin C 
after weaning (group 5). 
Group 1: Saline (1 ml/day, s.c.). 
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Group 2:  Nicotine (1mg/kg/day in 1 ml, s.c). 
Group 3:  Saline (1ml/day, s.c) and vitamin C (1g/l in the drinking water). 
Group 4:  Nicotine (1mg/kg/day in 1 ml, s.c) and vitamin C (1g/l in the drinking water). 
 
Female rats were treated as indicated above from day 3 after mating up to weaning on 
postnatal day 21. It is important to note that the offspring in group 1-4 were not treated with 
nicotine, saline or vitamin C. The fetuses and neonates were thus exposed to nicotine via the 
placenta and mother's milk. Animals in group 5 received vitamin C (1g/l) in the drinking 
water from weaning up to 5 months of age. The experimental design is shown in next flow 
diagram (figure 3.2). 
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Figure 3.2: Flow diagram showing the experimental design for the second study. 
 
Animals from group 1-4 (5 – 8 animals) were weighed (to determine the initial body weight) 
and sacrificed by exanguiation at 3 weeks of age, and blood samples were collected, and 
serum prepared as described below, for biochemical assays. Blood pressure of animals was 
measured every two weeks from 5 weeks of age. The weight of animals was also measured at 
two week intervals until 20 weeks (5 months) of age. At the end of the experimental period (5 
months) animals were anesthetized with sodium pentabarbital (100 mg/kg i.p.) and killed by 
exanguiation (when withdrawal reflex was absent after performing a toe pinch). Blood 
samples were again collected, and serum prepared, for further analysis. To prepare serum 
blood samples were collected from the thorax by pipette and transferred to Eppendorf tubes 
 
 
 
 
  32  
 
and left for 20 minutes to clot. The clear serum separated by centrifugation (3000 x g, 15 
min), was transferred to new Eppendorf tubes and stored at -20
o
C for further use.  
 
After the rats were killed (at 5 months old), the abdominal aorta was removed from 20 rats (4 
rats from each group) for histological and histochemical analysis. Aortic samples removed 
were fixed in 10% buffered formaldehyde solution (pH 7.2). A 10% buffered formaldehyde 
solution was prepared as follows: 4g of di-sodium hydrogen phosphate (anhydrous) 
(Na2HOP4) and 6g of sodium di-hydrogen phosphate di-hydrate (NaH2PO4.2H2O) were 
dissolved in 900 ml distilled water. Once the chemicals were dissolved in the water, 100 ml 
formaldehyde solution was added to make up a 1000 ml buffered formalin solution. 
 
3.3.1. Measurement of blood pressure 
Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) 
and heart rate (HR) were measured in rats by the tail-cuff method with a computerized blood 
pressure monitor (CODA blood pressure monitor, Kent Scientific, USA). This system uses a 
volume pressure method to determine blood pressure. The animals were put under light 
sedation to reduce handling stress, which could influence blood pressure measurement. To 
maintain blood flow to the tail, the animals were then placed on a heating pad while 
maintaining the ambient temperature at 30°C. The occlusion cuff was placed proximally on 
the tail of the animal and allowed to fit loosely for free movement of the tail. A volume 
pressure recording (VPR) cuff was placed distally behind the occlusion cuff. After that, about 
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three to six stable measurements of blood pressure were taken, and the averages of the 
readings were calculated. 
 
3.3.2. Serum biochemical assays 
Biochemical estimation of serum antioxidant systems was performed using a thiobarbituric 
acid reactive substance (TBARS) assay, superoxide dismutase (SOD) assay and total 
antioxidant capacity (TAC) assay. 
 
3.3.2.1.Total antioxidant capacity (TAC) assay 
The total antioxidant capacity assay is a spectrophotometric method that is used for 
measuring the total antioxidant capacity in human and animal serum. In the total antioxidant 
capacity assay kit, either the concentration of the combination of both small molecule and 
protein antioxidant, or the concentration of only small molecule antioxidants can be 
determined. The TAC assay is based on the reduction of copper (II) to copper (I) by 
antioxidants such as uric acid. Upon reduction, the copper (I) ion further reacts with a 
coupling chromogenic reagent that produces a color with a maximum absorbance at 570 nm. 
The color intensity is proportional to the total antioxidant capacity. In this study the assay was 
done with serum collected at five weeks (initial collection of blood) and at five months (final 
collection of blood) of age.  
 
In brief, the experimental protocol was as follows. The reagents and samples were allowed to 
warm to room temperature (about 30 minutes) prior to running the assay. All samples and 
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standards in this assay were run in duplicate on a 96-well plate. A standard curve was 
generated by adding different volumes (0, 8, 16, 24, 32, 40, 48 and 56 µl) of trolox standard 
to wells to get a different concentration. After that, water was added to each well of standard 
to bring the volume to 100 µl.  5 µl of serum was added to each of the sample wells followed 
by addition of 95 µl water to bring the final volume of 100 µl. For the assay reaction to 
develop, 100 µl of the Cu working solution was added to sample wells. The 96-well plate was 
protected from light using a thin foil during the incubation period. It was mixed using a 
horizontal shaker and incubated for 90 minutes at room temperature. Finally, the absorbance 
of standards and unknown samples was measured at 570 nm using a POLARstar omega 
spectrophotometer (BMG Labtech, Ortenberg, Germany). The standard curve generated was 
used to calculate sample TAC. The TAC activity of the samples was calculated using the 
equation obtained from the linear regression of the standard curve. Since the serum samples 
were diluted, values calculated were corrected by multiplying by the dilution factor (5x). The 
result was expressed as nmole of TAC per µl of sample volume. 
 
3.3.2.2.Thiobarbituric acid reactive substances (TBARS) assay 
The measurement of Thiobarbituric Acid Reactive Substances (TBARS) is a well-established 
method for screening and monitoring lipid peroxidation (LPO) (Yagi, 1998). This method 
depends on the formation of the lipid peroxidation (LPO) end product, malondialdehyde 
(MDA), which reacts with thiobarbituric acid (TBA) to produce a thiobarbituric acid reactive 
substance (TBARS), a pink chromogen which can be measured spectophotometrically at 532 
nm. Modifications of the thiobarbituric acid reactive substance (TBARS) assay by many 
researchers have been used to evaluate several types of samples including human and animal 
tissue and fluids, drugs, and foods (Richard et al., 1992). 
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The assay protocol of the experiment was as follows: 100 µl of MDA standards 
(malondialdehyde) with different concentration (0, 0.0625, 0.125, 0.25, 0.5, 1, 2.5 and 5 µM) 
and samples were added to a 5 ml tube, which was appropriately labeled. Thereafter, 100 µl 
of SDS solution and 4 ml of the color reagent were added to each tube and tubes were swirled 
to mix. The vials were capped and placed in a holder to keep the vials upright during boiling. 
The vials were boiled for an hour, after which they were immediately removed and placed in 
an ice bath for 10 minutes to stop the reaction. After 10 minutes, the vials were centrifuged 
for another 10 minutes at 1600 x g at 4 C°. 150 µl from each vial was loaded in duplicate to a 
clear plate (calorimetric version). The absorbance of the standards and unknown samples 
were read at 530 nm using a POLARstar omega spectrophotometer (BMG Labtech, 
Ortenberg, Germany). The standard curve generated was used to calculate TBARS of the 
samples. The result was expressed as nmol of MDA per ml of sample volume.  
 
3.3.2.3. Superoxide dismutase (SODs) assay  
Superoxide dismutases are metallo-enzymes that catalyze the dismutation of the superoxide 
anion to molecular oxygen and hydrogen peroxide thus forming a crucial part of the cellular 
antioxidant defence mechanism (Barik et al., 2005). The superoxide dismutase assay kit 
utilizes a tetrazolium salt for detection of superoxide radical generated by xanthine oxidase 
and hypoxanthine. 
 
In brief, the experimental protocol was as follows. All samples and standards in this assay 
were run in duplicate on a 96-well plate. For SOD standard wells, 200μl of the diluted radical 
detector and 10 μl of standards (SOD) with different concentration (1, 1.472, 1.752, 2, 2.89, 
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3.9971 and 4.75 U/ml) were added to each of the designated wells on the plate. For sample 
wells, 200 μl of the diluted radical detector and 10 μl of the sample were added to the sample 
wells. The reaction was initiated by adding 20 μl of diluted xanthine oxidase to all wells. The 
96-well plate was covered, carefully shaken for a few seconds to mix, and then the samples 
were incubated for 30 minutes at room temperature on a shaker. After 30 minutes, the 
absorbance of standards and unknown sample was read at 450 nm using a POLARstar omega 
spectrophotometer (BMG Labtech, Ortenberg, Germany). The standard curve generated was 
used to calculate sample SOD activity. The SOD activity of the samples was calculated using 
the equation obtained from the linear regression of the standard curve. The result was 
expressed as U (units) of SOD per ml of sample. 
 
3.3.3. Histology study 
3.3.3.1.Tissue Processing  
The aortic tissue was carefully removed from the 10 % buffered formaldehyde and placed on 
a clean glass tile and cleaned of connective tissue. The tissue was placed in a plastic tissue 
processing cassette that was properly labeled, and placed into a tissue processing rack of the 
automatic tissue processor (Leica TP 1020). The total duration of secondary fixation and wax 
impregnation was programmed for a 22-hour cycle (see table 3.3). Table 3.3 summarizes the 
tissue processing protocol. 
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3.3.3.2. Embedding 
After the 22-hour tissue processing cycle was completed, tissues were manually removed 
from cassettes in order to begin the tissue embedding procedure. Tissues were transferred into 
a mould in a standing position. Then, slowly a very small volume of warm wax was run into 
the mould, to ensure that the tissue sample was fully covered with wax. The mould was then 
placed on the refrigerated plate of the embedding system just for a few minutes to permit the 
wax to start solidifying. 
 
3.3.3.3. Sectioning  
When the tissue had solidified at the end of the embedding phase, the cassettes were removed 
from the mould. The tissue blocks were trimmed and cut into 5 μm sections for haematoxylin 
and eosin (H & E) staining. 
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Table 3.3:Tissue processing procedure for light microscopy. 
Step Solution Time (min) Temperature (ºC) 
1 
70 % alcohol 1 hr 
40 
2 
70 % alcohol 1 hr 
40 
3 
80 % ethanol 2 hr 
40 
4 
90 % ethanol 2 hr 
40 
5 
100 % ethanol 2 hr 
40 
6 
100 % ethanol 2 hr 
40 
7 
100 % ethanol 2 hr 
40 
8 
Xylene 2 hr 
40 
9 
Xylene 2 hr 
58 
10 
Parafine 2 hr 
58 
11 
Parafine 2 hr 
58 
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3.3.3.4.Mounting 
The 5 μm tissue sections were obtained from the embedded tissue and transferred to labelled 
microscope slides. This was done by allowing the cut sections of wax ribbon to float in a 
warm (60-70˚C) water bath (Electothermal paraffin section mounting bath) allowing the wax 
ribbon with the tissue section to flatten for easy picking with the microscope slide. The slides 
were left overnight to allow the tissue to be fixed onto the slide. Sections that broke up easily 
when placed in the water bath were excluded from the study. The labelled microscope slide 
was placed on a slide rack and placed in an incubator (Heraeus) at 80˚C for ± 30 min, to 
further fix the tissue and melt the wax, after which they were then stored in microscope slide 
boxes until staining was executed. 
 
3.3.3.5.Haematoxylin and Eosin Staining 
Standard haematoxylin and eosin (H&E) staining was used to prepare tissues for evaluation 
of structure. Standard haematoxylin and eosin (H&E) staining was carried out by an 
autostainer machine (Leica Auto Stainer XL) at the University of Stellenbosch, Cape Town, 
South Africa. The staining protocol used in this study is explained in the table 3.4 below: 
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Table 3-4: Procedure of Haematoxylin and Eosin staining. 
Step Chemical solution Time 
 
Deparaffination and Rehydration 
   
1 Xylene 10 min 5 min 
2 Ethanol (99%) 5 min 
3 Ethanol (95%) 2 min 
4 Ethanol (70%) 2 min 
5 Distilled water 5 sec 
Haematoxylin staining   
1 Haematoxylin 8 min 
2 Running water 5 min 
3 Ethanol (1% acid alcohol) 30 sec 
4 Running water 5 min 
5 Ammonia (0.2%) 45 sec 
6 Running water 5 min 
7 Ethanol (95%) 10 dips 
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Eosin Staining and Dehydration   
1 Eosin 45 sec 
2 Ethanol (95%) 5 min 
3 Xylene 5 min 
4 Mount for observation using DPX and 
slide cover slips 
 
 
 
3.3.3.6.Immunohistochemistry (IHC) staining for receptors of advanced glycation end 
products 
Tissue sections were prepared and mounted as described earlier. All immunohistochemical 
(IHC) staining procedure was performed using an automatic Leica Bond Autostainer with the 
Bond Polymer. 
 
Bond polymer detection was performed by incubating the specimen with hydrogen peroxide 
to quench endogenous peroxidase activity. The primary antibody was applied and Post 
Primary Immunoglobulin G (IgG) linker reagent was used as the postprimary antibody. Poly-
HRP (Horseradish peroxidase) IgG antibody was used as the second antibody and the 
substrate chromogen, 3, 3’-diaminobenzidine tetrahydrochloride (DAB) was used to visualize 
the complex as a brown precipitate. Finally, hematoxylin (blue) counterstaining was 
performed to allow for visualization of the cell nuclei.  
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The method of immunohistochemistry (IHC) applied staining is illustrated in the table 3.5 
below. 
 
Table 3-5: IHC staining protocol (standard protocol of the autostainer). 
Step Type Incubation Time Temperature 
1 Peroxide Block 5 min Ambient 
2 Bond Wash    
Solution 
2 min Ambient 
3 Bond Wash    
Solution 
2 min Ambient 
4 Bond Wash 
Solution 
2 min Ambient 
5 Primary 
Antibody 
15 min Ambient 
6 Bond Wash  
Solution 
2 min Ambient 
7 Bond Wash 
Solution 
2 min Ambient 
8 Bond Wash 
Solution 
2 min Ambient 
9 Post Primary 8 min Ambient 
10 Bond Wash 
Solution 
2 min Ambient 
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11 Bond Wash 
Solution 
2 min Ambient 
12 Bond Wash 
Solution 
2 min Ambient 
13 Polymer 8 min Ambient 
14 Bond Wash 
Solution 
2 min Ambient 
15 Bond Wash 
Solution 
2 min Ambient 
16 Deionized 
Water 
1 min Ambient 
17 Deionized 
Water 
1 min Ambient 
18 Mixed DAB 
Refine 
10 min Ambient 
19 Deionized 
Water 
1 min Ambient 
20 Deionized 
Water 
1 min Ambient 
21 Deionized 
Water 
1 min Ambient 
22 Hematoxylin 5min Ambient 
23 Deionized 
Water 
1 min Ambient 
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24 Deionized 
Water 
1 min Ambient 
25 Deionized 
Water 
1 min Ambient 
 
After immunohistochemistry (IHC) staining, the tissues were rehydrated and cleared. The 
rehydration was done as described in the next protocol (see table 3.6). 
 
Table 3-6: Rehydration protocol. 
Step Solution Duration 
1 70% alcohol 5 dips 
2 96% alcohol 5 dips 
3 96% alcohol 5 dips 
4 99% alcohol 5 dips 
5 99% alcohol 5 dips 
6 Xylene Dip for 1 min 
7 Xylene Dip for 1 min 
 
 
Thereafter, the PDX mounting medium was used to cover the glass slide. The slide was left to 
dry at 25 °C. The protein expression in aorta tissue was evaluated by microscopy using a 
Zeiss Microscope with objectives at 200 X and 400 X magnification. 
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3.4. Statistical analysis 
Data generated from this study was analyzed with GraphPad Prism 5.0. Results are shown as 
the mean ± SEM. Two groups were compared using a Student’s t-test, whereas multiple 
groups were compared by ANOVA (in all cases variances between groups were found to be 
equal). P< 0.05 is considered significant.  
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CHAPTER FOUR 
RESULTS 
 
4.1. Preliminary study 
4.1.1. Effect of nicotine exposure during pregnancy and lactation on the blood pressure 
of rat pups  
In a preliminary experiment, the blood pressure of 6 months old offspring (female and male) 
from rat dams exposed to nicotine during gestation and lactation was determined. The blood 
pressure of male pups was significantly higher (P<0.01) when compared with the control 
group (MAP= 111 ± 11.55 mm Hg vs 129 ± 12.66 mm Hg in control and the nicotine group, 
respectively; figure 4.1B), whereas blood pressure of female offspring was not significant 
(P>0.05) between the control and nicotine group (figure 4.1A). This could mean that male 
rats exposed to nicotine during pregnancy and lactation might be more susceptible to, and 
possess a higher risk of hypertension. Because of this observation all subsequent experiments 
were performed on male offspring only. 
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Figure 4.1: The effect of maternal nicotine exposure during gestation and lactation on the blood pressure of 
offspring at 6 months.                                                                                                                                                 
Female (A), Male (B), SBP= Systolic blood pressure, DBP= Diastolic blood pressure, MAP= Mean arterial 
pressure. Data is presented as the mean ± S.E.M, *P < 0.05. 
 
4.2. Second study 
4.2.1.  Effect of maternal exposure to nicotine during pregnancy and lactation on the 
body weight of the male offspring 
Body weight of male offspring was measured at 3 weeks after birth (weaning) and is 
considered as the initial body weight, and 5 months after birth (final body weight). The results 
show that the initial mean body weights of the four groups were approximately the same at 
week 3 (81.50 ± 2.9 g, 74 ± 2.50 g, 72.2 ± 2.40 g and 71.20 ± 4.30 g for saline, nicotine, 
saline + vitamin C and nicotine + vitamin C groups respectively; with P >0.05) as shown in 
table 4.1. 
 
A B 
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On the other hand, the final body weight of animals after 5 months shows that the mean body 
weight of the nicotine group (263 ± 6.6 g) and the group that received vitamin C after 
weaning (287.3 ± 6.3 g) was significantly reduced (P<0.001 and P<0.05, respectively) when 
compared with the control group (317 ± 5.4 g), see figure 4.2B. Animals exposed to nicotine 
and vitamin C during gestation and lactation (309.8 ± 5.3 g) and the group that received 
saline and vitamin C during pregnancy and lactation (303.5 ± 4.7 g) showed no change in 
body weight when compared with the control group (P>0.05; figure 4.2A). 
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Figure 4.2: The effect of nicotine and vitamin C on initial (A) and final body weight (B) of male offspring.  
Data is presented as mean ± SEM,*P < 0.05, ***P < 0.001 vs control. 
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Table: 4.1: Body weight of rats in the different groups at weaning (3 weeks) and at five months. 
Variables CN N S + C N + C CW 
 
Initial BW (g) 
 
81.5±2.9 
 
74±2.5 
 
72.2±2.4 
 
71.2±4.3 
 
N 8 5 7 5  
P (comparison to control)  >...0 >0.05 >0.05  
Final BW (g) 317±5.4 263±6.6 303.5±4.7 309.8±5.3 287±6.3 
N 9 7 10 7 8 
P (comparison to control)  <0.001 >0.05 >0.05 <0.01 
CN= Control, N= Nicotine, S+C= Saline+vitamin C, N+S= Nicotine+vitamin C, CW= vitamin C after weaning, 
C= vitamin C. P compared with control. N= number of rats. Values are expressed as the mean ± SEM. 
 
4.2.2. Effect of maternal exposure to nicotine during pregnancy and lactation on MAP 
and HR of the male offspring. 
The blood pressure of the nicotine group (exposed to nicotine during pregnancy and lactation) 
and control group was measured over the 5-month period after birth. The results show that the 
blood pressure of both groups was similar for the first two months (postnatal day 65) after 
which a steady increase in MAP was noticed in the nicotine group up to five months of age. 
From 3 months onwards, the blood pressure of the nicotine group was significantly higher (P 
< 0.05) when compared with the control group (figure 4.3). In the nicotine group MAP 
increased from 94.8±3.8 mm Hg in the 1
st
month to 121 ± 6.4 mm Hg at the 5
th
 month. 
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Figure 4.3: Blood pressure (MAP) in offspring over 5month period. 
Data is presented as mean ± SEM, *P < 0.05, **P < 0.01. 
 
Measurement of the baseline MAP at 5 weeks showed that the MAP of all groups was similar 
(P>0.05) and within the normal range (figure 4.4A and B).  
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Figure 4.4: Mean arterial pressure in the different experimental groups at 5 weeks. 
(A) Maternal vitamin C administration to the nicotine group during pregnancy and lactation. (B) Vitamin C 
administration to the nicotine group after weaning. Data is presented as mean ± SEM.  
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After the 5 month period, the MAP was significantly higher in the nicotine group (121±6.4 
mm Hg; P<0.01) as well as the nicotine + vitamin C group (113.4±1.7 mm Hg; P<0.05) when 
compared with the control group (98.1±2.4 mm Hg; figure 4.5A). The MAP of the group that 
received vitamin C after weaning (97.6±2.9 mm Hg; P>...0) was not significantly different 
from that of the control group (98.1±2.4 mm Hg), but it was significantly (P<0.01) less than 
that of the nicotine group (121±6.4; figure 4.5B). This shows that vitamin C administration 
after weaning reduces the nicotine induced increase in MAP.  
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Figure 4.5: Mean arterial pressure in the different experimental groups at 5 months. 
(A) Maternal vitamin administered to the nicotine group during pregnancy and lactation. (B) Vitamin C 
administration to the nicotine group after weaning. Data is presented as mean ± SEM,*P < 0.05, **P < 0.01 vs 
control. 
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After the 5 month period, both SBP and DBP were significantly higher in the nicotine group 
(SP = 147.1±6.1 mm Hg; P<0.001 and DP = 110.2±7.2 mm Hg; P<0.01, respectively) as well 
as the nicotine + vitamin C group (SP = 138.2±3.2 mm Hg; P<0.05 and DP = 102.5±3.4 mm 
Hg; P<0.01, respectively) when compared with the control group (SP = 121.1±1.7 mm Hg 
and DP = 83.9±3.0 mm Hg respectively) (table 4.2).  
 
The SBP and DBP of the group that received vitamin C after weaning (SP = 116.5±3.5 mm 
Hg and DP = 88.2±2.7 mm Hg, respectively) was not significantly different (P>...0) from 
that of the control group (SP = 121.1±1.7 mm Hg and DP = 83.9±3.0 mm Hg, respectively), 
but it was significantly (P<0.05) less than that of the nicotine group. This shows that vitamin 
C administration after weaning reduces the nicotine induced increase in SBP and DBP (table 
4.2). 
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Table 4.2: MAP, SBP and DBP in the different groups at 5 weeks and 5 months of age. 
Variables CN N S + C N + C CW 
Systolic blood pressure (SBP)      
Initial SBP (mm Hg) 118.5±2.8 115.1±4.6 113 ± 3.0 116.1±3.7 118.9±3.0 
N 9 7 10 7 8 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
Final SBP (mm Hg) 121.1±1.7 147.1±6.1 120.3±3.6 138.2±3.2 116.5±3.5 
N 9 7 10 7 8 
P (comparison to control)  <0.001 >0.05 <0.05 >0.05 
Diastolic blood pressure (DBP)      
Initial DBP (mm Hg) 90.8±3.1 84.7±3.4 81.2±4.3 88.0±3.3 89.4±3.3 
N 9 7 10 7 8 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
Final DBP (mm Hg) 83.9±3.0 110.2±7.2 95.8±4.2 102.5±3.4 88.2±2.7 
N 9 7 10 7 8 
P (comparison to control)  <0.01 >0.05 <0.01 >0.05 
Mean arterial pressure (MAP)      
Initial MAP (mm Hg) 97.8±2.7 94.8±3.8 91.9±3.7 97.4±3.4 99±3.0 
N 9 7 10 7 8 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
Final MAP (mm Hg) 98.1±2.4 121±6.4 104.1±4.6 113.4±1.7 97.6±2.9 
N 9 7 10 7 8 
P (comparison to control)  <0.001 >0.05 <0.01 >0.05 
N = number of rats. CN= control, N= nicotine, SC= saline+vit C, NC= nicotine+vit C, CW= nicotine+vit C after 
weaning. Values are expressed as the mean ± SEM. P<0.05 is considered significant (compared with control). 
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The heart rate was not significantly different (P>0.05) between groups at 5 weeks (figure 
4.6A and 4.7A) and 5 months (figure 4.6Band 4.7B). 
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Figure 4.6: The effect of maternal nicotine exposure during gestation and lactation, and vitamin C co-
administration on HR of the male offspring at five weeks (A) and at five months (B). 
Data is presented as mean ± SEM.   
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Figure 4.7: The effect of maternal nicotine exposure during gestation and lactation, and vitamin C 
administration after weaning on HR at five weeks (A) and at five months (B). 
Data is presented as mean ± SEM.  
A B 
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Table 4.3: The effect of maternal nicotine and vitamin C exposure during gestation and lactation on HR of the 
different groups at 5 weeks and 5 months of age. 
Variables CN N S + C N + C CW 
Heart rate (HR)      
Initial HR (bpm) 462±4.7 451.3±3.4 423.5±2.4 432.8±10.5 480±6.1 
N 9 7 10 7 8 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
Final HR (bpm) 422.4±7.3 421.9±6.1 396.2±11 365.4±11.4 405.1±7.7 
N 9 7 10 7 8 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
N= number of rats. CN= control, N= nicotine, SC= saline+vit C, NC= nicotine+vit C, CW= nicotine+vit C after 
weaning. Values are expressed as the mean ± SEM. P<0.05 is considered significant (compared with control). 
 
4.2.3. Serum Biochemical Analysis 
4.2.3.1. Lipid peroxidation (MDA) 
The standard curve generated in the MDA assay shows a linear relation between absorbance 
and MDA concentration (figure 4.8). The MDA concentration of the samples was calculated 
using the equation (Y= 0.0329x + 0.0183) obtained from the linear regression of the standard 
curve.  
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Figure 4.8: Standard Curve for the MDA assay. 
Values are given as mean ± SEM 
 
The results showed that at 5 weeks, the serum MDA content was not significantly different 
between the groups (P>0.05; figure 4.9). The values varied between 5.48 ± 0.6 µM (saline 
group) and 3.60 ± 0.6 µM (saline + vitamin C group).  
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Figure 4.9: MDA content of different groups in rat serum at 5 weeks. 
Values are given as mean ± SEM. 
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4.2.3.2 Superoxide dismutase activity (SOD) 
The standard curve generated in the SOD assay shows a linear relation between absorbance 
and SOD concentration (figure 4.10). The SOD activity of the samples was calculated using 
the equation (Y= 0.6209x + 0.0641) obtained from the linear regression of the standard curve.  
 
 
Figure 4.10: Standard Curve for the SOD assay. 
Values are given as mean ± SEM. 
 
The results showed that at 5 weeks, the serum SOD activity was not significantly 
different(P>0.05) between the groups (figure 4.11). The values were varied between 4.03 ± 
0.5 U/ml (saline group) and 2.93 ± 0.3 U/ml (nicotine + vitamin C group) 
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Figure 4.11: SOD activity of the different groups in male rat serum at 5 weeks. 
Values are given as mean ± SEM. 
 
4.2.3.3 Total antioxidant capacity (TAC) 
The TAC of serum samples at 5 weeks and at 5 months was calculated using the equations 
(Y= 0.0196x + 0.011 and Y= 0.0245x + 0.1244; respectively) obtained from the linear 
regression curve generated during the assay (figure 4.12). 
 
Figure 4.12: Standard Curve of the TAC assay at five weeks (A) and at five months (B). 
Values are given as mean ± SEM. 
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Total antioxidant capacity levels in the serum of all groups either at five weeks or at five 
months showed no significant differences (P>0.05; figure 4.13 and table 4.4). At five weeks, 
the values varied between 19.2 ± 0.8 nmol/ml and 15.8 ± 2.6 nmol/ml for the nicotine group 
and nicotine + vitamin C group, respectively, whereas at five months the values varied 
between 18.3 ± 1.5 nmol/ml and 14.3 ± 1.4 nmol/ml for the saline group and nicotine + 
vitamin C after weaning group, respectively. 
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Figure 4.13: TAC level of the different groups in rat serum at 5 weeks (A) and at 5 months (B and C). 
Values are given as the mean ± SEM. 
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Table 4.4: The summary result of biochemical assays done on the serum samples. 
Variable CN N SC NC CW 
Lipid peroxidation (MDA)      
LP 5.4±0.6 4.9±0.9 3.6±0.6 4.2±0.2  
N 4 4 4 4  
P (comparison to control)  >0.05 >0.05 >0.05  
Superoxide dismutase (SOD)      
SOD 4.0±0.5 3.7±0.2 3.4±0.3 2.9±0.3  
N 5 5 5 5  
P (comparison to control)  >0.05 >0.05 >0.05  
Total antioxidant capacity 
(TAC) 
     
TAC (five weeks) 17.5±0.8 19.2±0.8 15.8±2.6 17.2±1.7  
N 5 5 5 5  
P (comparison to control)  >0.05 >0.05 >0.05  
TAC (five months) 18.3±1.5 15.7±1.2 15.0±0.7 14.6±2.3 14.3±1.4 
N 7 7 7 7 7 
P (comparison to control)  >0.05 >0.05 >0.05 >0.05 
N = number of rats. CN= control, N= nicotine, SC= saline+vit C, NC= nicotine+vit C, CW= nicotine+vit C after 
weaning. Values are expressed as the mean ± S.E.M. P compared with control. TAC in nmole/ml; SOD in U/ml 
and MDA in µM 
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4.3. Histology Results 
4.3.1 Haematoxylin and Eosin staining  
Representative photomicrographs of transverse sections of the abdominal aorta from all the 
groups are shown in (figure 4.14). Sections of the control (saline) and saline + vitamin C 
group show regularity of the aorta wall and a normal arrangement of the three layers (tunica 
adventitia, tunica media and tunica intima), as well as the normal linear arrangement of 
smooth muscle cells (SMC) and endothelial cells (EC) (figure 4.14B and 4.14 D). 
 
Photomicrographs show irregular and abnormal alignment of the aorta wall with an irregular 
arrangement of the vascular smooth muscle cells (VSMCs) at the tunica media layers in the 
nicotine, nicotine + vitamin C groups, as well as in the group that received vitamin C after 
weaning (figure 4.14F, H and K) respectively. In these groups the elastic fibres appear wavy 
and intima protrusions are also observed. 
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Figure 4.14: Transverse sections of the abdominal aorta stained with hematoxylin and eosin (H and E stain). 
Plates A and C are photomicrograph of the transverse sections of saline (control) and saline+vit C groups. Aorta 
show regularity in the aortic wall and normal alignment of the three tunics (TA= Tunica adventitia, TM= Tunica 
media, TI= Tunica intima). Plates B and D are the higher magnification of plates A and C, and show the intima 
(TI), media (TM) and adventitia (TA). Plates E, G and I show photomicrographs of the transverse sections of the 
aorta from the nicotine, nicotine+vitamin C and nicotine+vitamin C groups after weaning. Irregular and 
abnormal alignment of the aortic wall of the three groups was observed. Plates F, H and K are the higher 
magnification plates E, G and I respectively. Blue arrows show the tunica intima (TI), abnormal arrangement of 
vascular smooth muscle cells (VSMC) in the media (TM) and adventitia (TA).  
The images in plates A, C, E, G and I were taken at 200X magnification, whereas the images in figure B, D, F, 
H and K were taken at 400X magnification. 
 
4.3.2 Immunohistochemistry (IHC)  
To assess the expression levels of advanced glycation end products (AGEs) in aortic tissue, 
immunohistochemistry (IHC) was performed on sections from the abdominal aorta using an 
antibody to AGEs. Representative photographs of immunostaining of aortic tissue in all the 
groups are shown in images 4.15A - K. In this study, the brown stain represents the presence 
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of the AGEs protein. Expression levels of AGEs were observed in all the groups but the 
staining intensity differed amongst groups. 
 
The saline and saline + vitamin C groups (figure 4.15 B and D, respectively) showed very 
little expression of AGEs, whereas the expression level of AGEs in the nicotine, nicotine + 
vitamin C and nicotine + vitamin C after weaning groups (figure 4.15 F, H and J, 
respectively) was much stronger.  
 
 
 
 
  65  
 
 
 
 
 
 
 
 
  66  
 
 
 
Figure 4.15: IHC of AGEs expression in abdominal aortic tissues from the five groups. 
Control (plates A&B), normal saline + vitamin C (plates C&D), nicotine (plates E&F), nicotine + vitamin C 
(plates G&H) and nicotine + vitamin C after weaning (plates I&J). The expression of AGEs in the all of the 
groups was indicated with a blue arrow. (TA= Tunica adventitia, TM= Tunica media, TI= Tunica Intiman). 
The images in plates A, C, E, G and I were taken at 200 x magnifications, whereas the images in plates B, D, F, 
H and K were taken at 400 x magnifications. 
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CHAPTERFIVE 
DISCUSSION 
 
5.1. Introduction 
Events that occur during fetal development are linked to long-term health in the adult. So for 
example, intrauterine growth restriction (IUGR), which sometimes occurs as a result of 
inadequacy of nutrients or disruptions in placental structure or function, could lead to a 
decrease in the expression of genes that are responsible for nephrogenesis. Survival of the 
fetus under these conditions, most times, results in low birth weight (LBW) and a deficit in 
nephron number, which are associated with hypertension in adulthood (Jones et al., 2012). 
Hypertension is a strong independent risk factor for well-known cardiovascular and 
cerebrovascular morbidities that include myocardial infarction, stroke and atherosclerosis 
(Staessen et al., 2003). 
 
A previous study has shown that sex hormones play a role in the progression of hypertension 
in adults subjected to intra uterine growth restriction(Black et al., 2015). It has been reported 
that while both male and female intra uterine growth restriction offspring are hypertensive 
early in life, only males remain hypertensive into adulthood (Ojeda et al., 2007).  
 
5.2. Body weight 
A strong relationship exists between the maternal nutrient intake during pregnancy and the 
body weight of infants (Parlee and MacDougald, 2014). In developing countries, the low birth 
 
 
 
 
  68  
 
weight infants have been shown to be affected by intrauterine growth restriction during 
pregnancy (Ramakrishnan, 2004). In pregnant women the placenta is the organ that transports 
nutrients, respiratory gases and wastes between the mother and the fetus (Tarrade et al., 
2015). Placental blood flow is thus essential for the fetus to grow, as well as the removal of 
waste products during metabolism. Maternal smoking during gestation was reported to have 
an adverse effect on the placenta function as it results in placental vasoconstriction. This 
vasoconstriction, in turn leads to a reduction of more than 40% in utero-placental blood flow 
(Birnbaum et al., 1994; Anblagan et al., 2013), which will compromise nutrient supply to the 
developing fetus ( Larsen et al., 2002). 
 
According to Mothibeli (2013), the body weight of 14 and 21 day-old offspring was not 
affected by maternal nicotine exposure during pregnancy. The results of this study concur 
with these findings and show that maternal exposure to nicotine had no effect on the body 
weight of male offspring at 3 weeks of age. In contrast to our findings after 3 weeks, the body 
weight of animals in the nicotine group was significantly lower after 5 months (figure 4.2B). 
Previous work has indicated that body weight loss induced by nicotine, probably is due to its 
effect on certain neurotransmitters that act in the control and regulation of appetite and satiety 
in the hypothalamus (Chatkin and Chatkin, 2007). Mineur et al (2011) also established that 
nicotine reduces the food intake and body weight of young offspring by influencing the 
hypothalamic melanocortin system and synaptic mechanisms involved in nicotine-induced 
decreases in appetite. 
 
 
 
 
 
 
  69  
 
5.3.  Effects of maternal nicotine exposure during pregnancy and lactation on blood 
pressure of female and male offspring 
Previous studies have indicated that the nicotine present in cigarette smoke has led to an 
increase in blood pressure and heart rate during smoking (Middlekauff et al., 2014; Omvik, 
1996). Furthermore, it was also established that maternal exposure to nicotine induces 
hypertension in male offspring (Gao et al., 2008; Xiao et al., 2014).  
 
My preliminary study demonstrated that maternal nicotine exposure during gestation and 
lactation increased blood pressure of male offspring but not of female offspring (figure 4.1); 
hence all my subsequent experiments were performed only on male offspring. These results 
correspond to studies conducted by Tao et al (2013) and Xiao et al (2008), where that BP was 
higher in the adult male offspring than in the female offspring as a result of nicotine exposure 
during pregnancy and lactation. This suggests a protective function of female sex hormones, 
such as estrogen, on perinatal exposure to nicotine induced hypertension. Xiao et al (2013) 
suggested that estrogen has a role in the sex difference of perinatal nicotine-induced 
programming of vascular dysfunction. They hypothesized that estrogen may counteract 
heightened reactive oxygen species production, resulting in protection of females from 
developmental programming of the hypertensive phenotype in adulthood. 
 
The result of this study also indicates that blood pressure in male offspring increased from the 
age of 12 weeks onwards for the male offspring of nicotine-exposed animals, this is supported 
by Ojeda et al (2007) who reported that while both male and female intra uterine growth 
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restriction offspring are hypertensive early in life, only males remain hypertensive into 
adulthood.  
 
The systolic blood pressure increased from 115.1±4.6 mm Hg in the first month to 147.1±6.1 
mm Hg in the fifth month, diastolic blood pressure increased from 84.7±3.4 mm Hg in the 
first month to 110.2±7.2 mm Hg in the fifth month, and mean arterial pressure increased from 
94.8±3.8 mm Hg in the first month to 121±6.6 mm Hg in the fifth month. Our results at five 
months of age are similar to previous studies which also indicated that the blood pressure of 
offspring exposed to nicotine during pregnancy and lactation was increased at 14 weeks of 
age (Gao et al., 2008). Gao et al (2008) however, did not measure the blood pressure in the 
very young animals. 
 
Nicotine may lead to an increase of blood pressure via nicotine receptors found on peripheral 
chemoreceptor cells in the central nervous system. The peripheral chemoreceptor cells are 
located near the carotid arteries and aorta and bear a significant stimulatory effect on 
ventilation and sympathetic activity (Gonzalez et al., 1994; Ciarka et al., 2005). Ciarkaet al 
(2005) hypothesized that nicotine elevates peripheral sympathetic nerve activity to smooth 
muscle, causing vasoconstriction. In addition, heart rate is also increased due to sympathetic 
nervous system activation (Triposkiadis et al., 2009). Our results show that exposure to 
maternal nicotine did not raise HR although an increase in the blood pressure was observed, 
suggesting that the observed hypertension is probably not due to activation of the sympathetic 
nervous system. This will however require further investigation. 
 
 
 
 
  71  
 
5.4. Effect of vitamin C supplementation on development of hypertension in animals 
exposed to nicotine during gestation and lactation 
In human, a decrease in the concentration of Vit C in plasma has been associated with 
hypertension as well as impaired endothelial function (Juraschek et al., 2012). Houston 
(2005) suggested a dose-dependent relationship between blood pressure and plasma ascorbate 
levels. It was also shown that ascorbic acid (2.4 mg/100ml) has beneficial effects on 
endothelium-dependent vasodilatation, and these beneficial effects could be related to the 
scavenging of oxygen free radicals (Akpaffiong and Taylor, 1998; Taddei et al., 1998). 
Administration of 1g of vitamin C per day reduced SBP by 7 mm Hg and DBP by 4 mm Hg 
(Bates et al., 1998).  
 
It is possible that the intake of nicotine during gestation and lactation via tobacco smoking or 
via nicotine replacement therapy could reduce the blood and tissue vitamin C content of the 
neonate, thereby rendering it more vulnerable to oxidant damage. We could also posit that 
nicotine intake reduces the vitamin C content of the mother’s blood and thus the potential of 
the mother to protect the offspring against the harmful effects resulting from nicotine. Lower 
serum vitamin C levels in maternal nicotine exposure could be caused by impaired vitamin C 
absorption or increased vitamin C breakdown. Maternal vitamin C supplementation during 
gestation and lactation could help prevent the deleterious effect of nicotine as it will ensure 
that a reasonable amount of vitamin C is available for development of the fetus and neonate. 
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Many studies have also shown the effect of maternal antioxidant therapy on the other body 
organs. In the lung, a previous human trial has suggested that maternal intake of antioxidant 
(vitamin E) is associated with a reduced risk of respiratory disease (such as wheeze and 
asthma) of offspring (Devereux et al., 2006). It has also reported that administration of 
vitamin C and E during pregnancy could diminish adiposity in the offspring (Sen and 
Simmons, 2010). Damage of the fetal brain caused by cell death via apoptosis is due to 
oxidative stress, and can be reduced by using antioxidants during pregnancy and lactation 
(Shirpoor et al., 2009). 
 
The results from our study show that maternal vitamin C supplementation in rats exposed to 
nicotine during pregnancy and lactation did not prevent development of hypertension of the 
male offspring. Contrary to this, vitamin C given to pups after weaning significantly 
improved the nicotine induced hypertension of male offspring as it leads to a reduction in the 
blood pressure. Our results also show that supplementation with vitamin C after weaning 
leads to a reduction of both systolic and diastolic blood pressure (table 4.2). It was observed 
that systolic blood pressure was reduced more than diastolic blood pressure 30.6±8.8 mmHg 
and 22±10.4 mmHg, respectively, when compare with the nicotine group. To our knowledge 
this is the first time that it is shown that hypertension induced by nicotine exposure during 
pregnancy and lactation, can be attenuated or even reversed.  
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5.5. Effect of vitamin C supplementation on serum oxidative parameters 
Oxidative stress is caused by an imbalance between the antioxidants and the reactive oxygen 
species, resulting in damage to cells or tissues. Several micronutrients are of vital importance 
to health due to its antioxidant properties (Mocchegiani et al., 2014). It is now widely 
believed that diet derived antioxidants play a role in the prevention of human disease and 
deficiency of the dietary derived antioxidants may prejudice fetal and childhood development 
(Evans and Halliwell, 2001). 
 
The measurement of TBARS is well established method for screening and monitoring lipid 
peroxidation. MDA is one of the most prevalent byproducts of lipid peroxidation during 
oxidative stress (Yagi, 1998). SOD is thought to play a very important role in protecting 
living cells against toxic oxygen derivatives. The enzyme catalyzes the dismutation of two 
superoxide radicals into O2 and H2O2 (Sun et al., 1988). The TAC assay can measure either 
the combination of both small molecule and protein antioxidants or small molecules 
antioxidant alone in the presence of protein mask. In this study we thus used a three pronged 
approach to evaluate of maternal nicotine exposure and vitamin C (an antioxidant) 
supplementation on the antioxidant capacity of the offspring. 
 
Maternal exposure to nicotine during pregnancy and lactation resulted in an increased 
oxidative stress in fetal, neonatal, and adult tissues (Wetscher et al., 1995; Crowley-Weber et 
al., 2003; Zhao and Reece, 2005). In our result, we did not find any significant difference in 
serum activity of MDA, SOD or TAC (figure 4.9, 4.11 and 4.13) among the groups at five 
weeks. The difference in the result might be attributed to the difference in the chosen dose of 
nicotine in this study compared with other studies where nicotine was proven to induce 
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oxidative stress. In this study, the dose of nicotine (1mg/kg/day) was very low compared with 
previous studies (>4 mg/kg/day) (Crowley-Weber et al., 2003; Zhao and Reece, 2005). It may 
also be due to the fact that the studies by Crowley-Weber et al., (2003) and Zhao and Reece 
(2005), evaluated oxidative stress in tissue and not in serum. Our finding however 
corresponds with a previous study which concluded that the concentration of vitamin C as 
well as total antioxidant status in nicotine treated rats, were not altered amongst groups, but a 
significant decrease of vitamin E was observed (Helen et al., 2000). 
 
In this study, we used vitamin C as an antioxidant to determine whether taking vitamin C 
supplements will help or prevent the effects of oxidative stress in the serum, induced by 
nicotine. Since some offspring received vitamin C during pregnancy and lactation, and others 
received vitamin C after weaning, total antioxidant capacity assay was tested at 5 weeks and 
at 5 months. The total antioxidant capacity in the serum of animals at 5 weeks and 5 months 
of nicotine withdrawal was not significant different between any of the groups. The findings 
imply that neither nicotine, nor vitamin C supplementation, prompted any change in the 
antioxidant capacity at 5 weeks or at 5 months. Therefore, and due to the cost of these assays, 
we did not test the TBARS and SOD assays again at five months. In contrast to this result, 
previous research from our laboratory showed that vitamin C decreased oxidative status in 
animal tissue (Daramola, 2015) which is more in line with the results of Crowley-Weber et 
al., (2003) mentioned earlier. 
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5.6. Histology and immunochemistry 
5.6.1. Morphology study 
A morphometric study on aorta tissue from hypertensive rats has shown alteration in the 
architectural layout of the layers (Intengan and Schiffrin, 2001; Zarkovic et al., 2015). In 
hypertension, artery structure changes are mainly of two kinds: (1) inward eutrophic 
remodelling, in which outer and lumen diameters are decreased, i.e. media/lumen ratio is 
increased, and cross-sectional area of the media is unaltered; and (2) hypertrophic 
remodelling, in which the media thickens and encroach on the lumen, resulting in increased 
media cross-sectional area and media/lumen ratio (Intengan and Schiffrin, 2001).  
 
The results of a study conducted by Intengan and Schiffrin (2001) is in agreement with our 
study which indicates that fetus and neonatal nicotine exposure leads to increased blood 
pressure and morphological alterations in the layers of the aorta, characterized by irregular 
and abnormal alignment of the aortic wall. The alteration in the layers of the aorta tissue in 
the group that received the combination of nicotine and vitamin C during pregnancy and 
lactation, and the group that received vitamin C after weaning, was similar to the alteration of 
the nicotine group (figure 4.14). This indicates that maternal vitamin C supplementation 
during gestation and lactation or, treating the offspring after weaning, did not prevent the 
effects of maternal nicotine exposure on the aorta tissue of the offspring. In contrast to our 
study, Maritz (1993) illustrated that maternal vitamin C supplementation during pregnancy 
and lactation prevented the structural changes in the lung of the offspring induced by 
maternal nicotine exposure (Maritz, 1993).  
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It is interesting that, although the alteration in aortic structure persisted, supplementation with 
vitamin C did reduce nicotine induced hypertension in our study. Grossman et al (2001), 
suggested that vitamin C modifies the redox state of soluble guanylyl cyclase, activating 
cyclic GMP–dependent K-channels that hyperpolarize VSMC, inducing vasodilation. In view 
of the fact that the structure of the aortic wall in the nicotine + vitamin C group resembles that 
of the nicotine group, it will be of interest to see how vascular function is affected in the 
nicotine + vitamin C group when the animals become older. The vitamin C induced 
protection can perhaps be attributed to the fact that vitamin C is water soluble while nicotine 
is water as well as lipid soluble (Yildiz, 2004). This may reduce the capacity of vitamin C to 
protect the aorta against the oxidant effects of nicotine in aorta wall. Thus, a combination of 
vitamin C and fat soluble vitamins with anti-oxidant properties, such as vitamin E or vitamin 
A, is recommended. 
 
5.6.2. Immunohistochemistry study  
AGEs elicit oxidative stress generation and subsequently cause inflammatory in various types 
of cells via interaction with a receptor for AGEs (RAGE), thereby being involved in vascular 
complications. In diabetes, it was suggested that pathophysiological crosstalk between the 
AGE–RAGE axis and the renin–angiotensin system (RAS) could contribute to the 
progression of vascular damage (Yamagishi et al., 2012). 
 
In this study, anti-AGE antibody which is specific for AGE was used for 
immunohistochemical staining of the aorta. AGE staining helps to reveal the extracellular 
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deposition and intracellular accumulation of AGEs in the atherosclerosis lesions of rat aorta 
(Sano et al., 1999).  
 
From our result, it was observed that there was AGE accumulation among the groups treated 
with nicotine. Taken together, we could infer that accumulation of AGE which is related to 
atherosclerosis progression might be as a result of the relationship between extracellular and 
intracellular AGE accumulation and hypertension. These findings correlate to studies 
conducted by Treweek et al., (2009) who reported that accumulation of AGE was increased 
in nicotine treated rats. Treweek et al., (2009) also hypothesized that nornicotine, a minor 
metabolite of nicotine, induces the advanced glycation end products in the serum samples of 
smokers. 
 
The accumulation of AGE in nicotine + vitamin C group and the group that received vitamin 
C after weaning was similar to nicotine treated rats, and is similar to our morphological 
results. As discussed previously, vitamin C may exert its protective effects via modification 
of the soluble guanylyl cyclase activity despite the structural alterations, at least in the 
beginning. It will thus be of interest to measure blood pressure in the animals at a later age. 
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CHAPTER SIX 
CONCLUSION 
 
In this project I studied the effect of low dose maternal nicotine exposure on the BP of the 
male offspring at five months old. We were particularly interested to determine whether 
hypertension induced by maternal nicotine exposure can be prevented or attenuated by 
vitamin C (antioxidant) supplementation during the perinatal period or after weaning. Since 
we expected the offspring to become hypertensive and hoped that our interventions will 
attenuate the hypertension which developed due to maternal nicotine exposure, we also 
evaluated the serum antioxidant capacity, aorta morphology and AGE expression in the aorta. 
 
The results show maternal exposure to 1mg/kg/day nicotine during pregnancy and lactation 
caused the male, but not the female, offspring to develop hypertension. The male offspring 
were not hypertensive at weaning but were hypertensive at three months. Maternal vitamin C 
co-administration during pregnancy and lactation did not prevent the male offspring from 
becoming hypertensive. If the offspring were however given vitamin C after weaning, they 
did not develop hypertension. To our knowledge it is the first time that it has been showed 
that hypertension which develops due to maternal nicotine exposure can be reversed. Serum 
antioxidant capacity, as evaluated by the TAC, SOD activity and TBARS assay showed no 
significant difference between groups. Our results suggests that the stimulus/trigger for 
development of hypertensionis probably during pregnancy, and perhaps also lactation, but 
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that therapeutic intervention must be when the offspring develops hypertension. Vitamin C 
thus did not neutralise the trigger, but prevented development of the disease. 
Maternal nicotine exposure induced morphological changes in the structure of the aorta and 
increased the expression of AGE, which were not prevented by vitamin C administration. 
 
Future perspectives: 
To determine whether hypertension which develops as a result of maternal nicotine exposure 
is truly a phenomenon of fetal programming future experiments should include experiments 
to determine whether maternal nicotine exposure during pregnancy only, or during lactation 
only will cause hypertension in the offspring.  It will also be of interest to determine whether 
epigenetic changes occurred. 
 
It will be important to establish whether vitamin C administration, when the animals are 
already hypertensive (e.g. at 3 or 4 months) will attenuate hypertension. The timing of 
vitamin C administration may be crucial. 
 
In order to further investigate the mechanism by which vitamin C prevented development of 
hypertension in our study, it will be necessary to evaluate oxidative stress in aortic tissue. It 
will also be useful to evaluate the effect of nicotine on vascular reactivity in the presence or 
absence of vitamin C.  
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